OVULEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ovulen, and what generic alternatives are available?
Ovulen is a drug marketed by Gd Searle Llc and is included in two NDAs.
The generic ingredient in OVULEN is ethynodiol diacetate; mestranol. There is one drug master file entry for this compound. Additional details are available on the ethynodiol diacetate; mestranol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OVULEN?
- What are the global sales for OVULEN?
- What is Average Wholesale Price for OVULEN?
Summary for OVULEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| DailyMed Link: | OVULEN at DailyMed |
US Patents and Regulatory Information for OVULEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gd Searle Llc | OVULEN | ethynodiol diacetate; mestranol | TABLET;ORAL-20 | 016029-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | OVULEN-21 | ethynodiol diacetate; mestranol | TABLET;ORAL-21 | 016029-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | OVULEN-28 | ethynodiol diacetate; mestranol | TABLET;ORAL-28 | 016705-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
